fbpx

Definitive Healthcare Stock: Commercial Intelligence SaaS

October 6. 2021. 5 mins read

It’s easy to understand why the market assigns a premium to software-as-aservice (SaaS) business models. Typically, such companies have a broad customer base with no single customer accounting for more than a small fraction of revenues. They’re usually high-growth companies where the more customers brought on board, the higher the margins. And most importantly, they provide easy-to-follow metrics that anyone can understand – even an MBA.

Annual recurring revenues (ARR) better be growing steadily, gross retention rate ought to be in the high 90s, and net retention rate ought to be above 100%. Those three metrics alone can tell you a lot about a SaaS business’s health. We love SaaS business models so much we recently added a flag to our tech stock catalog which denotes whether a company is “pure SaaS,” “some SaaS,” or “no SaaS.” Today, we’re going to talk about a pure SaaS play called Definitive Healthcare (DH).

About Definitive Healthcare Stock

Click for company website

Founded in 2011, Bahstun’s own Definitive Healthcare is a $3.65 billion company that recently has an initial p

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.